Redline editor — Per-patient budget

CARDINAL-02 · Royal Prince Alfred Hospital · Phase II oncology

RM

Site proposal · Round 3

Sarah Nguyen, RPA · submitted 2h ago

Your counter · Round 2 baseline

Avance Clinical (CRO) · editing draft

FMV source NaCTA 2025 · NSW metro

Quantities assume 8 visits · 1 screening, 6 treatment, 1 follow-up

Line item Qty Site asks Your counter Δ vs FMV Decision
Procedures · 5 visits-worth · $5,740

Screening visit — full panel

ECG, bloods, imaging review

1 $1,240 $1,240 +1.2%
Accepted

Treatment visit — infusion + monitoring

Per-visit, includes 4h chair time

6 $3,180 $2,940 +9.4%
Countered
RM

You · just now

Infusion chair time benchmarks at $2,940 for NSW metro under NaCTA 2025. Happy to revisit if you can attach the costing breakdown.

SN

Sarah Nguyen · RPA · 2h ago

RPA pharmacy applies a 4-hour minimum chair charge — that's the gap. Costing sheet attached to PICF v3.

Follow-up / end-of-study visit

Safety review + final bloods

1 $1,320 $1,320 −0.4%
Accepted
Pharmacy dispensing · $2,250

IMP dispensing & accountability

Per dispensing event

6 $1,500 $1,500 +2.1%
Accepted

Cold-chain storage surcharge

No FMV benchmark — site-specific

1 $750
+17.2%
Open
Institutional overhead · applied at 25% basis

RPA institutional overhead

Site standard rate, % of direct costs

— 30% 25% cap 25%
Countered
Start-up & pass-through · one-off

Site start-up & SSA fee

Governance, ethics submission support

1 $8,500 $8,500 at FMV
Accepted

Pharmacy set-up (pass-through)

Reconciled at actuals

1 $625 $625 pass-through
Accepted

Tip: edit a "Your counter" value to log a redline. Accepted lines carry across to the CTRA automatically.